Peggy

First sale of APAS Independence
||
PAC Partners Analyst Report - Analyst report from PAC Partners following the first sale of APAS Independence to St Vincent's Hospital in Melbourne
continue reading
Bioshares Biotech Summit presentation summary
||
The Investment Proposition Does the Means Justify the End? Brent Barnes CEO LBT Innovations addresses the topic at the 14th Biotech Summit
continue reading
LBT Innovations Market Update
||
Bioshares Analyst Report - Targets for LBT Innovations based on sales of the APAS Independence instrument and ongoing software licences.
continue reading
APAS Independence wins award at MDEA
||
The APAS Independence, the product of Clever Culture Systems, has won Silver at the Medical Design Excellence Awards in New York.
continue reading
APAS Independence – MDEA award Finalist
||
The APAS Independence, the product of Clever Culture Systems, has been nominated as a finalist in the Medical Design Excellence Awards.
continue reading
Using AI to automate clinical microbiology
||
Australian Government grant initiative. Business.com.au Research and Development Tax Incentives - Customer Story on LBT Innovations
continue reading
Extraordinary General Meeting Presentation 2018
||
Presentation by Brent Barnes Chief Executive Officer & Managing Director of LBT Innovations at this April's Extraordinary General Meeting
continue reading
Artificial Intelligence for Pathology Bottlenecks
||
LBT’s APAS® received regulatory approval and patents over the last 18 months. Its first evaluation trial at St Vincent Hospital was successfully completed.
continue reading
APAS Installed at First Hospital Site
||
Bioshares Analyst Report following LBT Innovations installation of its first APAS Independence instrument in Melbourne, at St Vincent's Hospital.
continue reading
Under The Radar Report Small CAP Research
||
Robotics is a hot investment theme and LBT has been riding the wave of interest with its device to automate the processing and analysis of biological samples.
continue reading